Related Experiment Video

Updated: Aug 4, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Stockpile levels for pediatric vaccines: how much is enough?

Sheldon H Jacobson1, Edward C Sewell, Ruben A Proano

  • 1Department of Mechanical and Industrial Engineering, 1206 West Green Street (MC-244), University of Illinois, Urbana, IL 61801, United States. shj@uiuc.edu

Vaccine
|March 9, 2006
PubMed

Insights

Pediatric vaccine supply shortages can be mitigated by optimizing national stockpile levels. This study uses a stochastic inventory model to determine appropriate vaccine stockpile sizes and funding to ensure timely childhood immunizations and prevent disease outbreaks.

Area of Science:

  • Public Health
  • Epidemiology
  • Supply Chain Management

Background:

  • Vaccine production interruptions have led to supply shortages, impacting timely childhood immunizations in the US.
  • These shortages risk epidemic outbreaks of preventable childhood diseases.
  • The Centers for Disease Control and Prevention (CDC) utilizes national pediatric vaccine stockpiles to manage these disruptions.

Purpose of the Study:

  • To analyze the adequacy of CDC-proposed pediatric vaccine stockpile levels.
  • To determine appropriate stockpile levels for achieving vaccination coverage targets.
  • To calculate funding requirements for optimal pediatric vaccine stockpiles.

Main Methods:

  • A stochastic inventory model was employed to analyze vaccine stockpile levels.
  • The model considered historical vaccine production interruption durations (averaging over 1 year).
  • Analysis focused on ensuring sufficient supply to meet vaccination schedules.

Main Results:

  • The study assesses the sufficiency of current CDC-proposed stockpile levels.
  • It provides data-driven recommendations for optimal pediatric vaccine stockpile quantities.
  • Estimated funding needs for establishing adequate stockpiles are reported.

Conclusions:

  • Optimized pediatric vaccine stockpile levels are crucial for maintaining vaccination schedules during production interruptions.
  • The findings offer insights for public health policy regarding vaccine supply chain resilience.
  • Adequate funding is essential to support robust national vaccine stockpiles.

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Consistent Delivery of Adeno-Associated Virus via Lateral Tail-Vein Injection in Adult Mice05:03

Consistent Delivery of Adeno-Associated Virus via Lateral Tail-Vein Injection in Adult Mice

Published on: August 23, 2024

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.